Core Viewpoint - The leading Chinese snack and beverage retail brand, Mingming Hen Mang, has successfully passed the Hong Kong Stock Exchange listing hearing, attracting significant industry attention due to its robust and sustainable expansion in the franchise model, even after surpassing 10,000 stores [1]. Franchise Growth - Mingming Hen Mang's franchise business has shown strong growth momentum, with net growth rates of franchisees reaching 142.44%, 239.74%, and 114.42% from 2022 to 2024 [4]. - In the first half and the first three quarters of 2025, the net growth rates of franchisees were 15.70% and 31.91%, respectively, indicating a steady growth trend despite the increasing scale of operations [4]. - By the end of Q3 2025, the total number of franchisees had increased to 9,552, a significant rise from 410 at the beginning of 2022, reflecting strong market recognition of the brand's business model and development potential [4]. Store Operations - The average daily order volume per store increased from 385 orders in 2022 to 458 orders in the first half of 2025, further rising to 481 orders in the first three quarters of 2025, which supports franchisee profitability and the stability of the franchise ecosystem [4]. Store Count and Growth - The number of stores has grown significantly, with self-operated stores increasing from 4 in 2022 to 23 by September 2025, while franchise stores surged from 1,898 to 19,494 in the same period [5][6]. Franchise Support System - Mingming Hen Mang has established a comprehensive support system for franchisees, emphasizing that the success of franchisees equates to the brand's success, which includes site selection, training, operations, and supply chain management, all without charging franchise fees [7][8]. - The brand provides professional site evaluation services and customized store design solutions to help franchisees optimize their operations [7]. Low Closure Rate - The brand maintains a low closure rate, with rates of 0.74%, 0.67%, and 2.60% from 2022 to 2024, and further decreasing to 0.76% and 1.08% in the first half and first three quarters of 2025, indicating a healthy franchise ecosystem [11]. - This low closure rate, combined with high net growth rates, showcases the brand's strong operational foundation and competitive advantage in the snack retail sector [11]. Future Outlook - With a solid operational foundation and forward-looking ecological layout, Mingming Hen Mang is positioned for continued quality growth and sustainable development in the competitive retail industry [12]. - The brand aims to further enhance its franchisee support system and deepen supply chain integration to achieve win-win development with franchisees, contributing positively to the sustainable growth of China's snack retail industry [12].

Core Viewpoint - The China Securities Regulatory Commission has approved the overseas listing and domestic full circulation registration of Hunan Mingming Henbang Commercial Chain Co., Ltd, indicating a significant step in the company's expansion strategy [1] Group 1: Company Details - Hunan Mingming Henbang plans to issue up to 76,666,400 overseas listed common shares and list them on the Hong Kong Stock Exchange [1] - A total of 25 shareholders intend to convert their combined 198,079,551 shares of unlisted domestic stock into overseas listed shares for trading on the Hong Kong Stock Exchange [1] Group 2: Timeline and Process - The company first submitted its listing application to the Hong Kong Stock Exchange on April 28, 2025, and updated its application materials on October 28, 2025, to continue the listing process [1]

Core Viewpoint - The article discusses the rapid growth and challenges faced by Wancheng Biological, particularly its "Haoxianglai" brand, which has expanded to over 15,000 stores but is burdened by high debt and operational risks due to increased competition and extended payback periods for franchisees [2][3][4][5]. Financial Performance - Wancheng Biological's revenue surged from 5.49 billion yuan in 2022 to 323.29 billion yuan by mid-2025, with a significant increase in the share of snack and beverage retail business from 12.1% in 2022 to 98.9% in 2025 [6]. - The adjusted net profit showed a dramatic increase, reaching approximately 9.22 billion yuan in the first half of 2025, reflecting a growth rate of 287.39% year-on-year [8]. - Despite high revenue growth, the net profit margin has declined significantly, with a net profit margin of only 3.85% in the first half of 2025, compared to historical levels of around 10% to 20% from 2018 to 2021 [8]. Expansion Strategy - The company has aggressively expanded its franchise network, growing from 160 franchise stores in 2022 to 15,300 by mid-2025, with over 99% of its stores being franchises [6][7]. - Wancheng Biological's debt has increased dramatically, with current liabilities rising from approximately 3.32 billion yuan at the end of 2022 to 51.28 billion yuan by the end of 2024 [10]. Market Position - "Haoxianglai" has become the leading brand in the snack retail sector, holding a market share of 0.91%, while the top five brands collectively hold only about 3.85% of the market [20]. - The competitive landscape is characterized by a duopoly between Wancheng Biological and Mingming Group, with both companies vying for market share in a fragmented industry [21]. Operational Challenges - Franchisees are facing increased operational challenges, with the payback period for opening a "Haoxianglai" store extending from about one year to three years due to rising costs and market saturation [9][15]. - The company has reported significant increases in inventory levels, which could pose risks to its operations if not managed effectively [16]. Leadership and Governance - The founder of Wancheng Biological, Wang Jiankun, is under investigation, leading to concerns about governance and stability within the company [17][18]. - Wang Zening, the founder's son, has taken on a more prominent role in the company, which may influence its strategic direction moving forward [18][19].